Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS), 54217-54218 [2022-19013]

Download as PDF Federal Register / Vol. 87, No. 170 / Friday, September 2, 2022 / Notices FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company; Correction This notice corrects a notice (FR Doc. 2022–18061) published on page 51418 in the first column of the issue for Monday, August 22, 2022. Under A. Federal Reserve Bank of Chicago, entry 1 is corrected to read as follows: 1. Bernard Bennett Banks, Evanston, Illinois, as trustee of the Voting Trust Agreement, Miami, Florida; to acquire voting shares of National Bancorp Holdings, Inc., and thereby indirectly acquire voting shares of The Federal Savings Bank, both of Chicago, Illinois. Comments on this application must be received by September 19, 2022. Board of Governors of the Federal Reserve System. Michele Taylor Fennell, Deputy Associate Secretary of the Board. [FR Doc. 2022–19081 Filed 9–1–22; 8:45 am] Board of Governors of the Federal Reserve System. Michele Taylor Fennell, Deputy Associate Secretary of the Board. [FR Doc. 2022–19082 Filed 9–1–22; 8:45 am] BILLING CODE P BILLING CODE 4163–18–P FEDERAL RESERVE SYSTEM Notice of Closed Meeting VerDate Sep<11>2014 16:40 Sep 01, 2022 Jkt 256001 Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention The notificants listed below have applied under the Change in Bank Control Act (Act) (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the applications are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The public portions of the applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s Freedom of Information Office at https://www.federalreserve.gov/foia/ request.htm. Interested persons may express their views in writing on the standards enumerated in paragraph 7 of the Act. Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than September 19, 2022. Officer, Office of Extramural Programs, National Institute for Occupational Safety and Health, CDC, 1095 Willowdale Road, Morgantown, West Virginia 26505; Telephone: (304) 285– 5812; Email: DHartley@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. [FR Doc. 2022–19014 Filed 9–1–22; 8:45 am] BILLING CODE P Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company lotter on DSK11XQN23PROD with NOTICES1 A. Federal Reserve Bank of St. Louis (Holly A. Rieser, Senior Manager) P.O. Box 442, St. Louis, Missouri 63166– 2034. Comments can also be sent electronically to Comments.applications@stls.frb.org: 1. KJ Jansen, LP, and Robert G. Willenborg, individually and as general partner of KJ Jansen, LP, both of Effingham, Illinois; as a group acting in concert, to acquire voting shares of Prime Banc Corp., and thereby indirectly acquire voting shares of Dieterich Bank, both of Effingham, Illinois. 54217 Centers for Disease Control and Prevention Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— RFA–OH–22–005, Commercial Fishing Occupational Safety Research Cooperative Agreement; and RFA–OH– 22–006, Commercial Fishing Occupational Safety Training Project Grants. Date: November 15, 2022. Time: 1:00 p.m.–4:00 p.m., EST. Place: Video-Assisted Meeting. Agenda: To review and evaluate grant applications. FOR FURTHER INFORMATION CONTACT: Dan Hartley, Ed.D., Scientific Review PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS). This meeting is open to the public. Time will be available for public comment. DATES: The meeting will be held on October 24, 2022, from 11:00 a.m. to 5:20 p.m., EDT. ADDRESSES: Instructions to access the live meeting broadcast will be posted here: https://www.cdc.gov/nchs/about/ bsc/bsc_meetings.htm. FOR FURTHER INFORMATION CONTACT: Rebecca Hines, M.H.S., Designated Federal Officer, Board of Scientific Counselors, NCHS, CDC, 3311 Toledo Road, Mailstop P–08, Hyattsville, Maryland 20782; Telephone: (301) 458– 4715; Email: RSHines@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Board is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the SUMMARY: E:\FR\FM\02SEN1.SGM 02SEN1 54218 Federal Register / Vol. 87, No. 170 / Friday, September 2, 2022 / Notices Director, NCHS, regarding the scientific and technical program goals and objectives, strategies, and priorities of NCHS. Matters To Be Considered: The meeting agenda will include a Center update by the NCHS Director in addition to updates on NCHS data collection, analysis, and reporting activities, including upcoming changes to the National Hospital Ambulatory Medical Care Survey (NHAMCS); status of a National Ambulatory Medical Care Survey (NAMCS) pilot and plans for obtaining clinician visit data; a new project to improve metadata and catalogs for the public to access restricted use data files; and new releases of linked data sets. The Board’s Workgroup to Consider and Assess Measures of Discrimination for Use in NCHS Surveys will brief the Board with findings from 6 months of informationgathering and assessment work. The Committee will reserve time for public comment at the end of the day. Meeting times and topics are subject to change as priorities dictate. Meeting Information: Please visit the BSC, NCHS website for details: https:// www.cdc.gov/nchs/about/bsc/bsc_ meetings.htm. Further information and the meeting agenda will be available on the BSC website, including instructions for accessing the live meeting broadcast. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–19013 Filed 9–1–22; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES lotter on DSK11XQN23PROD with NOTICES1 Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: VerDate Sep<11>2014 16:40 Sep 01, 2022 Jkt 256001 ACTION: Notice of meeting. In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board). This meeting is open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcomed to listen to the meeting by joining the teleconference (information below). The audio conference line has 150 ports for callers. DATES: The meeting will be held on October 20, 2022, from 11:00 a.m. to 1:00 p.m., EDT. Written comments must be received on or before October 13, 2022. ADDRESSES: You may submit comments by mail to: Sherri Diana, National Institute for Occupational Safety and Health (NIOSH), CDC, 1090 Tusculum Avenue, Mailstop C–34, Cincinnati, Ohio 45226. Meeting Information: Audio Conference Call via FTS Conferencing. The USA toll-free dial-in number is 1– 866–659–0537; the passcode is 9933701. FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C–24, Cincinnati, Ohio 45226; Telephone: (513) 533–6800, Toll Free 1(800) CDC– INFO; Email ocas@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, SUMMARY: PO 00000 Frm 00032 Fmt 4703 Sfmt 9990 which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and rechartered under Executive Order 13889 on March 22, 2022, and will terminate on March 22, 2024. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters To Be Considered: The agenda will include discussions on the following: Work Group and Subcommittee Reports; Update on the Status of SEC Petitions; and plans for the December 2022 Advisory Board Meeting. Agenda items are subject to change as priorities dictate. For additional information, please contact Toll Free 1(800) 232–4636. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–19012 Filed 9–1–22; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\02SEN1.SGM 02SEN1

Agencies

[Federal Register Volume 87, Number 170 (Friday, September 2, 2022)]
[Notices]
[Pages 54217-54218]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19013]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Health 
Statistics (BSC, NCHS)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
National Center for Health Statistics (BSC, NCHS). This meeting is open 
to the public. Time will be available for public comment.

DATES: The meeting will be held on October 24, 2022, from 11:00 a.m. to 
5:20 p.m., EDT.

ADDRESSES: Instructions to access the live meeting broadcast will be 
posted here: https://www.cdc.gov/nchs/about/bsc/bsc_meetings.htm.

FOR FURTHER INFORMATION CONTACT: Rebecca Hines, M.H.S., Designated 
Federal Officer, Board of Scientific Counselors, NCHS, CDC, 3311 Toledo 
Road, Mailstop P-08, Hyattsville, Maryland 20782; Telephone: (301) 458-
4715; Email: [email protected].

SUPPLEMENTARY INFORMATION:
    Purpose: The Board is charged with providing advice and making 
recommendations to the Secretary, Department of Health and Human 
Services; the Director, CDC; and the

[[Page 54218]]

Director, NCHS, regarding the scientific and technical program goals 
and objectives, strategies, and priorities of NCHS.
    Matters To Be Considered: The meeting agenda will include a Center 
update by the NCHS Director in addition to updates on NCHS data 
collection, analysis, and reporting activities, including upcoming 
changes to the National Hospital Ambulatory Medical Care Survey 
(NHAMCS); status of a National Ambulatory Medical Care Survey (NAMCS) 
pilot and plans for obtaining clinician visit data; a new project to 
improve metadata and catalogs for the public to access restricted use 
data files; and new releases of linked data sets. The Board's Workgroup 
to Consider and Assess Measures of Discrimination for Use in NCHS 
Surveys will brief the Board with findings from 6 months of 
information-gathering and assessment work. The Committee will reserve 
time for public comment at the end of the day. Meeting times and topics 
are subject to change as priorities dictate.
    Meeting Information: Please visit the BSC, NCHS website for 
details: https://www.cdc.gov/nchs/about/bsc/bsc_meetings.htm. Further 
information and the meeting agenda will be available on the BSC 
website, including instructions for accessing the live meeting 
broadcast.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-19013 Filed 9-1-22; 8:45 am]
BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.